PortalPublikationenMonitoring Therapy Efficiency in Cancer through Extracellula...

Monitoring Therapy Efficiency in Cancer through Extracellular Vesicles

Standard

Monitoring Therapy Efficiency in Cancer through Extracellular Vesicles. / Stevic, Ines; Buescher, Gustav; Ricklefs, Franz Lennard.

in: CELLS-BASEL, Jahrgang 9, Nr. 1, 06.01.2020.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung

Harvard

Stevic, I, Buescher, G & Ricklefs, FL 2020, 'Monitoring Therapy Efficiency in Cancer through Extracellular Vesicles', CELLS-BASEL, Jg. 9, Nr. 1. https://doi.org/10.3390/cells9010130

APA

Stevic, I., Buescher, G., & Ricklefs, F. L. (2020). Monitoring Therapy Efficiency in Cancer through Extracellular Vesicles. CELLS-BASEL, 9(1). https://doi.org/10.3390/cells9010130

Vancouver

Stevic I, Buescher G, Ricklefs FL. Monitoring Therapy Efficiency in Cancer through Extracellular Vesicles. CELLS-BASEL. 2020 Jan 6;9(1). https://doi.org/10.3390/cells9010130

Bibtex

@article{591c0b23306e4463b4b4d72ee44322bb,
title = "Monitoring Therapy Efficiency in Cancer through Extracellular Vesicles",
abstract = "Extracellular vesicles (EVs) are a heterogeneous group of membrane-enclosed vesicles made of a phospholipid bilayer and are secreted by all cell types. EVs are present in a variety of body fluids containing proteins, DNA, RNA species, and lipids, and play an important role in cell- to-cell communication and are worth being considered as biomarkers for both early diagnosis of cancer patients and real-time monitoring of treatment response. Recently, emerging evidence verified EVs to have crucial roles in cancer progression and metastasis and a great potential in therapeutic applications. In this review, we discuss the potential of EVs in monitoring the efficacy of cancer therapies.",
author = "Ines Stevic and Gustav Buescher and Ricklefs, {Franz Lennard}",
year = "2020",
month = jan,
day = "6",
doi = "10.3390/cells9010130",
language = "English",
volume = "9",
journal = "CELLS-BASEL",
issn = "2073-4409",
publisher = "MDPI Multidisciplinary Digital Publishing Institute",
number = "1",

}

RIS

TY - JOUR

T1 - Monitoring Therapy Efficiency in Cancer through Extracellular Vesicles

AU - Stevic, Ines

AU - Buescher, Gustav

AU - Ricklefs, Franz Lennard

PY - 2020/1/6

Y1 - 2020/1/6

N2 - Extracellular vesicles (EVs) are a heterogeneous group of membrane-enclosed vesicles made of a phospholipid bilayer and are secreted by all cell types. EVs are present in a variety of body fluids containing proteins, DNA, RNA species, and lipids, and play an important role in cell- to-cell communication and are worth being considered as biomarkers for both early diagnosis of cancer patients and real-time monitoring of treatment response. Recently, emerging evidence verified EVs to have crucial roles in cancer progression and metastasis and a great potential in therapeutic applications. In this review, we discuss the potential of EVs in monitoring the efficacy of cancer therapies.

AB - Extracellular vesicles (EVs) are a heterogeneous group of membrane-enclosed vesicles made of a phospholipid bilayer and are secreted by all cell types. EVs are present in a variety of body fluids containing proteins, DNA, RNA species, and lipids, and play an important role in cell- to-cell communication and are worth being considered as biomarkers for both early diagnosis of cancer patients and real-time monitoring of treatment response. Recently, emerging evidence verified EVs to have crucial roles in cancer progression and metastasis and a great potential in therapeutic applications. In this review, we discuss the potential of EVs in monitoring the efficacy of cancer therapies.

U2 - 10.3390/cells9010130

DO - 10.3390/cells9010130

M3 - SCORING: Review article

C2 - 31935901

VL - 9

JO - CELLS-BASEL

JF - CELLS-BASEL

SN - 2073-4409

IS - 1

ER -